Dr Gunn has over 30 years of experience in medical devices and diagnostics. Most recently he was CEO of IDbyDNA, a metagenomics company based in the US that was acquired by Illumina in 2022. Prior to this he was the President of Roche Sequencing Solutions where he oversaw all aspects of the business and managed a team of approximately 900 people. His team developed and launched more than 20 products per year. He was also previously Vice President of Roches Molecular Diagnostics business and was responsible for over 120 diagnostic product launches principally into the IVD clinical market. He is Member of the Technology Committee.
